Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies
Milan Tomana, … , Karel Konecny, Jiri Mestecky
Milan Tomana, … , Karel Konecny, Jiri Mestecky
Published July 1, 1999
Citation Information: J Clin Invest. 1999;104(1):73-81. https://doi.org/10.1172/JCI5535.
View: Text | PDF
Article Article has an altmetric score of 6

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies

  • Text
  • PDF
Abstract

Circulating immune complexes (CICs) isolated from sera of patients with IgA nephropathy (IgAN) consist of undergalactosylated, mostly polymeric, and J chain–containing IgA1 and IgG antibodies specific for N-acetylgalactosamine (GalNAc) residues in O-linked glycans of the hinge region of IgA1 heavy chains. Antibodies with such specificity occur in sera of IgAN patients, and in smaller quantities in patients with non-IgA proliferative glomerulonephritis and in healthy controls; they are present mainly in the IgG (predominantly IgG2 subclass), and less frequently in the IgA1 isotype. Their specificity for GalNAc was determined by reactivity with IgA1 myeloma proteins with enzymatically removed N-acetylneuraminic acid (NeuNAc) and galactose (Gal); removal of the O-linked glycans of IgA1 resulted in significantly decreased reactivity. Furthermore, IgA2 proteins that lack the hinge region with O-linked glycans but are otherwise structurally similar to IgA1 did not react with IgG or IgA1 antibodies. The re-formation of isolated and acid-dissociated CICs was inhibited more effectively by IgA1 lacking NeuNAc and Gal than by intact IgA1. Immobilized GalNAc and asialo-ovine submaxillary mucin (rich in O-linked glycans) were also effective inhibitors. Our results suggest that the deficiency of Gal in the hinge region of IgA1 molecules results in the generation of antigenic determinants containing GalNAc residues that are recognized by naturally occurring IgG and IgA1 antibodies.

Authors

Milan Tomana, Jan Novak, Bruce A. Julian, Karel Matousovic, Karel Konecny, Jiri Mestecky

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1997 1991 1960 Total
Citations: 6 18 15 19 36 11 16 16 14 24 10 24 16 24 16 15 11 16 19 11 10 9 5 4 11 10 1 1 1 1 390
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (390)

Title and authors Publication Year
Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy
Sindhuri Prakash, Nicholas Steers, Yifu Li, Elena Sanchez-Rodriguez, Miguel Verbitsky, Isabel Robbins, Jenna Simpson, Sharvari Pathak, Milan Raska, Colin Reily, Anna Ng, Judy Liang, Natalia DeMaria, Amanda Katiraei, Kelsey Stevens, Clara Fischman, Samantha Shapiro, Swetha Kodali, Jason McCutchan, Heekuk Park, Djamila Eliby, Marco Delsante, Landino Allegri, Enrico Fiaccadori, Monica Bodria, Maddalena Marasa, Elizabeth Raveche, Bruce A. Julian, Anne-Catrin Uhlemann, Krzysztof Kiryluk, Hong Zhang, Vivette D'Agati, Simone Sanna-Cherchi, Jan Novak, Ali Gharavi
Journal of Clinical Investigation 2025
Exploring the causal role of pathogen-derived antibodies in major urinary and kidney diseases: Insights from generalized summary data-based Mendelian randomization
Huang H, Chen B, Feng C, Chen W, Wu D
Virulence 2025
Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines
Puagsopa J, Tongviseskul N, Jaroentomeechai T, Meksiriporn B
Vaccines 2025
Emerging biochemical and immunological mechanisms in the pathogenesis of IgA nephropathy
Novak J, Reily C, Steers NJ, Schumann T, Rizk DV, Julian BA, Kiryluk K, Gharavi AG, Green TJ
Seminars in nephrology 2025
Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide
Keskinis C, Moysidou E, Stai S, Christodoulou M, Lioulios G, Vamvakas SS, Trivyza MS, Pateinakis P, Papasotiriou M, Stangou M
Medicina 2025
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy
Dreher L, Nilges L, Wiech T, Rinschen MM, Tomas NM
Clinical Kidney Journal 2025
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.
Cheung CK, Barratt J, Liew A, Zhang H, Tesar V, Lafayette R
2024
Insights on Nefecon(®), a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy.
Barratt J, Kristensen J, Pedersen C, Jerling M
Drug design, development and therapy 2024
The Expression of Non B Cell-Derived Immunoglobulins.
Zheng J, Li G, Liu W, Deng Y, Xu X
Advances in experimental medicine and biology 2024
IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings
Suzuki H, Novak J
Journal of Clinical Medicine 2024
Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice
Kinashi Y, Tanaka K, Kimura S, Hirota M, Komiyama S, Shindo T, Hashiguchi A, Takahashi D, Shibata S, Karaki SI, Ohno H, Hase K
eBioMedicine 2024
Contemporary review of IgA nephropathy
Filippone EJ, Gulati R, Farber JL
Frontiers in Immunology 2024
Causal association between peripheral immune cells and IgA nephropathy: a Mendelian randomization study
Liang LM, Xiong L, He XL, Song LJ, Wang X, Lu YZ, Ye H, Ma WL, Yu F
Frontiers in Immunology 2024
The pathogenesis of IgA nephropathy and implications for treatment.
Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J
Nature reviews. Nephrology 2024
Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy
Makita Y, Reich HN
Journal of Clinical Medicine 2024
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy
Novak J, King RG, Yother J, Renfrow MB, Green TJ
Glycobiology 2024
Pathogenesis of IgA Nephropathy: Omics Data Inform Glycomedicine
Novak J
Nephrology (Carlton, Vic.) 2024
Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan
Aoki R, Nihei Y, Matsuzaki K, Suzuki H, Kihara M, Ogawa A, Nishino T, Sanada S, Yokote S, Okabe M, Shirai S, Fukuda A, Hoshino J, Kondo D, Yokoo T, Kashihara N, Narita I, Suzuki Y
Kidney360 2024
My Lifetime in IgA Nephropathy: An Unexpected Journey
Julian BA
Nephrology (Carlton, Vic.) 2024
Exploring the mediating role of immune cells in the pathogenesis of IgA nephropathy through the inflammatory axis of gut microbiota from a genomic perspective.
Huang H, Chen B, Feng C, Chen W, Wu D
Mammalian genome : official journal of the International Mammalian Genome Society 2024
Lessons from IgA Nephropathy Models
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Aoki R, Yamada K, Muto M, Suzuki Y
International Journal of Molecular Sciences 2024
Immunoglobulin A Antibodies: From Protection to Harmful Roles
Gleeson PJ, Camara NO, Launay P, Lehuen A, Monteiro RC
Immunological Reviews 2024
What is new in the pathogenesis and treatment of IgA glomerulonephritis
Salvadori M, Rosso G
World Journal of Nephrology 2024
Roles of Streptococcus mutans in human health: beyond dental caries
Fang Y, Chen X, Chu CH, Yu OY, He J, Li M
Frontiers in Microbiology 2024
IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease
Mestecky J, Julian BA, Raska M
Frontiers in immunology 2023
Omics are Getting Us Closer to Understanding IgA Nephropathy.
Mucha K, Pac M, Pączek L
Archivum Immunologiae et Therapiae Experimentalis 2023
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
Nihei Y, Suzuki H, Suzuki Y
Frontiers in immunology 2023
GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy
Jemelkova J, Stuchlova Horynova M, Kosztyu P, Zachova K, Zadrazil J, Galuszkova D, Takahashi K, Novak J, Raska M
Kidney International Reports 2023
Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway.
Xu W, Song W, Chen S, Jin S, Xue X, Min J, Wang X, You P
Frontiers in pharmacology 2023
IgA nephropathy associated with Crohn's disease
Tamura H
World Journal of Methodology 2023
The Effects of Perilla frutescens Extracts on IgA Nephropathy: A Systematic Review and Meta-Analysis
Adam G, Adam AM, Robu S, Harabor V, Harabor A, Nechita A, Marin DB, Morariu ID, Cioanca O, Vasilache IA, Hancianu M
Pharmaceuticals 2023
[Diagnosis and Treatment of IgA Nephropathy-2023].
Schimpf J, Kronbichler A, Windpessl M, Zitt E, Eller K, Säemann MD, Lhotta K, Rudnicki M
Wiener klinische Wochenschrift 2023
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.
Rajasekaran A, Green TJ, Renfrow MB, Julian BA, Novak J, Rizk DV
Drugs 2023
The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies
Tang Z, Yu S, Pan Y
Journal of Translational Medicine 2023
IgA nephropathy.
Stamellou E, Seikrit C, Tang SCW, Boor P, Tesař V, Floege J, Barratt J, Kramann R
Nature Reviews Disease Primers 2023
Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores
Rizk DV, Novak L, Hall SD, Moldoveanu Z, Julian BA, Novak J, Haas M
Journal of Clinical Medicine 2023
Differentiating primary and secondary FSGS using non-invasive urine biomarkers.
Catanese L, Siwy J, Wendt R, Amann K, Beige J, Hendry B, Mischak H, Mullen W, Paterson I, Schiffer M, Wolf M, Rupprecht H
Clinical Kidney Journal 2023
Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.
Tumoglu B, Keelaghan A, Avci FY
Glycobiology 2023
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG
The New England journal of medicine 2023
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
D Lin, C Chang, Y Hsu, C Lin
International journal of molecular sciences 2022
Development and Evaluation of a Robust Sandwich Immunoassay System Detecting Serum WFA-Reactive IgA1 for Diagnosis of IgA Nephropathy
Uenoyama Y, Matsuda A, Ohashi K, Ueda K, Yokoyama M, Kyoutou T, Kishi K, Takahama Y, Nagai M, Ohbayashi T, Hotta O, Matsuzaki H
International journal of molecular sciences 2022
Sialylation as an Important Regulator of Antibody Function
Vattepu R, Sneed SL, Anthony RM
Frontiers in immunology 2022
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors
Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M
Journal of the American Society of Nephrology : JASN 2022
Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy
Person T, King RG, Rizk DV, Novak J, Green TJ, Reily C
Journal of Interferon & Cytokine Research 2022
The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy
Sanchez-Russo L, Rajasekaran A, Bin S, Faith J, Cravedi P
2022
IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers
Xu L, Li Y, Wu X
Frontiers in immunology 2022
Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
Ohyama Y, Yamaguchi H, Ogata S, Chiurlia S, Cox SN, Kouri NM, Stangou MJ, Nakajima K, Hayashi H, Inaguma D, Hasegawa M, Yuzawa Y, Tsuboi N, Renfrow MB, Novak J, Papagianni AA, Schena FP, Takahashi K
iScience 2022
Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement.
Delapierre A, Terrier B, Pillebout E, Baudart P, Jourde-Chiche N, Lioger B, Martis N, Moulis G, Rivière E, Le Gouellec N, Raffray L, Urbanski G, Sanges S, Maurier F, Deroux A, Mekinian A, Monteiro R, Marcelli C, Guillevin L, Maillot F, Lucas B, Aouba A, Audemard-Verger A
Clinical Rheumatology 2022
Crohn's disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy.
Akiyama M, Shimomura K, Yoshimoto H, Sako M, Kodama M, Abe K, Gunji M, Kang D, Takaki T, Wada Y, Iyoda M, Honda K
Virchows Archiv : an international journal of pathology 2022
Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.
Zhu X, Shen X, Lin B, Fang J, Jin J, He Q
Frontiers in pharmacology 2022
Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis.
Harraka P, Wightman T, Akom S, Sandhu K, Colville D, Catran A, Langsford D, Pianta T, Barit D, Ierino F, Skene A, Mack H, Savige J
Scientific Reports 2022
Identification and characterization of circulating immune complexes in IgA nephropathy.
Matsumoto Y, Aryal RP, Heimburg-Molinaro J, Park SS, Wever WJ, Lehoux S, Stavenhagen K, van Wijk JAE, Van Die I, Chapman AB, Chaikof EL, Cummings RD
Science Advances 2022
Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Reily C, Rice T, Crossman DK, Rizk DV
Journal of Autoimmunity 2022
Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
Luvizotto MJ, Menezes-Silva L, Woronik V, Monteiro RC, Câmara NO
Frontiers in Cell and Developmental Biology 2022
Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Kato R, Aoki R, Yamada K, Muto M, Suzuki Y
Biomedicines 2022
Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease.
Xiang T, Qiao M, Xie J, Li Z, Xie H
Biomolecules 2022
Metabolic signatures of immune cells in chronic kidney disease
Li J, Yang Y, Wang Y, Li Q, He F
Expert Reviews in Molecular Medicine 2022
Low-molecular weight inhibitors of the alternative complement pathway.
Schubart A, Flohr S, Junt T, Eder J
Immunological Reviews 2022
Propensity of Immunoglobulin A Self-aggregation via ‘Tailpiece’ Cysteine-471 and Treatment of IgA Nephropathy Using Cysteamine
Xinfang Xie, Li Gao, Pan Liu, Jicheng Lv, Wan-Hong Lu, Hong Zhang, Jing Jin
JCI Insight 2021
Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy
H Zeng, L Wang, J Li, S Luo, Q Han, F Su, J Wei, X Wei, J Wu, B Li, J Huang, P Tang, C Cao, Y Zhou, Q Yang
Cell & Bioscience 2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Antibody Glycosylation
M Pezer
2021
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics
Tilo Freiwald, Behdad Afzali
Advances in immunology 2021
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
A Bordron, M Morel, C Bagacean, M Dueymes, P Pochard, A Harduin-Lepers, C Jamin, JO Pers
International journal of molecular sciences 2021
Fantastic IgA plasma cells and where to find them
B Isho, A Florescu, AA Wang, JL Gommerman
Immunological Reviews 2021
Renal deposition and clearance of recombinant poly‐ IgA complexes in a model of IgA nephropathy
X Xie, P Liu, L Gao, X Zhang, P Lan, V Bijol, J Lv, H Zhang, J Jin
The Journal of Pathology 2021
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
Y Ohyama, MB Renfrow, J Novak, K Takahashi
Journal of Clinical Medicine 2021
Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment
B Knoppova, C Reily, RG King, BA Julian, J Novak, TJ Green
Journal of Clinical Medicine 2021
IgA glycosylation and immune complex formation in IgAN
H Suzuki, J Novak
Seminars in Immunopathology 2021
IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment
L Lai, S Liu, M Azrad, S Hall, C Hao, J Novak, BA Julian, L Novak
Journal of Clinical Medicine 2021
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy
Z Moldoveanu, H Suzuki, C Reily, K Satake, L Novak, N Xu, ZQ Huang, B Knoppova, A Khan, S Hall, H Yanagawa, R Brown, CJ Winstead, DB O'Quinn, A Weinmann, AG Gharavi, K Kiryluk, BA Julian, CT Weaver, Y Suzuki, J Novak
Journal of Autoimmunity 2021
IgA vasculitis with nephritis: update of pathogenesis with clinical implications
MC Hastings, DV Rizk, K Kiryluk, R Nelson, RS Zahr, J Novak, RJ Wyatt
Pediatric Nephrology 2021
Comparative Long-Term Renal Allograft Outcomes of Recurrent Immunoglobulin A with Severe Activity in Kidney Transplant Recipients with and without Rituximab: An Observational Cohort Study
W Chancharoenthana, A Leelahavanichkul, W Ariyanon, S Vadcharavivad, W Phumratanaprapin
Journal of Clinical Medicine 2021
Pathogenesis of IgA Vasculitis: An Up-To-Date Review
Y Song, X Huang, G Yu, J Qiao, J Cheng, J Wu, J Chen
Frontiers in immunology 2021
Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis
AA Abokor, GH McDaniel, RM Golonka, C Campbell, S Brahmandam, BS Yeoh, B Joe, M Vijay-Kumar, P Saha
Microorganisms 2021
The microbiome and IgA nephropathy
K Haniuda, JL Gommerman, HN Reich
Seminars in Immunopathology 2021
Poly-IgA Complexes and Disease Severity in IgA Nephropathy
X Zhang, J Lv, P Liu, X Xie, M Wang, D Liu, H Zhang, J Jin
Clinical journal of the American Society of Nephrology : CJASN 2021
Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance
J Zeng, RP Aryal, K Stavenhagen, C Luo, R Liu, X Wang, J Chen, H Li, Y Matsumoto, Y Wang, J Wang, T Ju, RD Cummings
Science Advances 2021
Immune Characteristics of IgA Nephropathy With Minimal Change Disease.
Li H, Lu W, Li H, Liu X, Zhang X, Xie L, Lan P, Yu X, Dai Y, Xie X, Lv J
Frontiers in pharmacology 2021
The immune landscape of IgA induction in the gut
C Seikrit, O Pabst
Seminars in Immunopathology 2021
Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies
MB Stang, PJ Gleeson, MR Daha, RC Monteiro, C van Kooten
Molecular Immunology 2021
A Fresh Perspective on Monoclonal Gammopathies of Renal Significance
P Aucouturier, VD DAgati, P Ronco
Kidney International Reports 2021
PATHOLOGY AND RENAL OUTCOME OF THREE UNCOMMON FACES OF CRESCENTRIC GLOMERULONEPHRITIS
K Basu, D Sircar, M Bandopadhyay
2021
Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease
HW Kim, JT Park, YS Joo, SC Kang, JY Lee, S Lee, TI Chang, EW Kang, DR Ryu, TH Yoo, HJ Chin, SW Kang, SH Han
Journal of Nephrology 2021
Streptococcus mutans induces IgA nephropathy-like glomerulonephritis in rats with severe dental caries
S Naka, K Wato, T Misaki, S Ito, D Matsuoka, Y Nagasawa, R Nomura, M Matsumoto-Nakano, K Nakano
Scientific Reports 2021
IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis.
Mitarai Y, Nakashima K, Fukunaga S, Ishikawa N, Ito T, Tsubata Y, Isobe T
Internal Medicine 2021
Proceedings of 16th International Symposium on IgA Nephropathy
Kidney Diseases 2021
Erythrocytosis associated with IgA nephropathy
Cohen C, Coulon S, Bhukhai K, Neuraz A, Dussiot M, Fouquet G, Stang MB, Flamant M, Vrtovsnik F, Hummel A, Knebelmann B, Mesnard L, Rondeau E, Maciel TT, Favale F, Casadevall N, Nguyen-Khoa T, Moutereau S, Legendre C, Benhamou M, Monteiro RC, Hermine O, El Karoui K, Moura IC
EBioMedicine 2021
Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
K Zachova, P Kosztyu, J Zadrazil, K Matousovic, K Vondrak, P Hubacek, BA Julian, Z Moldoveanu, Z Novak, K Kostovcikova, M Raska, J Mestecky
Frontiers in immunology 2020
The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
S Chang, XK Li
Frontiers in Medicine 2020
Quantitative assessment of successive carbohydrate additions to the clustered O -glycosylation sites of IgA1 by glycosyltransferases
TJ Stewart, K Takahashi, N Xu, A Prakash, R Brown, M Raska, MB Renfrow, J Novak
Glycobiology 2020
Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival
M Eder, N Kozakowski, H Omic, C Aigner, J Kläger, B Perschl, R Reindl-Schwaighofer, G Bond, GA Böhmig, Ž Kikić
Journal of Nephrology 2020
CDR3 sequences in IgA nephropathy are shorter and exhibit reduced diversity
, J Zeng, Y Tong, L Zhang, X Lu, S Zhu, Z Li
FEBS Open Bio 2020
IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study
S Peng, W Lu, X Jiang, X Xu, Y Wu
Renal Failure 2020
Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives
T Gan, Y Li, X Zhou, H Zhang
International journal of biological sciences 2020
Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers
C Jacobs-Cachá, A Vergara, C García-Carro, I Agraz, N Toapanta-Gaibor, G Ariceta, F Moreso, D Serón, J López-Hellín, MJ Soler
Clinical Kidney Journal 2020
Emerging Modes of Treatment of IgA Nephropathy
D Maixnerova, V Tesar
International journal of molecular sciences 2020
The analysis of treatment of Immunoglobulin A-nephropathy
VA Dobronravov, ZS Kochoyan, TO Muzhetskaya, DI Lin
2020
Simultaneous Immunoglobulin A and G Glycopeptide Profiling for High-Throughput Applications
A Momčilović, N de Haan, AL Ederveen, A Bondt, CA Koeleman, D Falck, LA de Neef, WE Mesker, R Tollenaar, A de Ru, P van Veelen, M Wuhrer, V Dotz
Analytical Chemistry 2020
Role of CD8+ T cells in crescentic glomerulonephritis
A Chen, K Lee, T Guan, JC He, D Schlondorff
Nephrology Dialysis Transplantation 2019
A New Vision of IgA Nephropathy: The Missing Link
F Sallustio, C Curci, VD Leo, A Gallone, F Pesce, L Gesualdo
International journal of molecular sciences 2019
The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
DV Rizk, N Maillard, BA Julian, B Knoppova, TJ Green, J Novak, RJ Wyatt
Frontiers in immunology 2019
IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2
TJ Stewart, K Takahashi, RH Whitaker, M Raska, WJ Placzek, J Novak, MB Renfrow
Glycobiology 2019
Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
G Li, X Wang, Z Yang, Q Zhao, Y Wen, X Li, R Gao
Disease Markers 2019
Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation
B Wehbi, C Oblet, F Boyer, A Huard, A Druilhe, F Paraf, E Cogné, J Moreau, YE Makhour, B Badran, MV Egmond, M Cogné, JC Aldigier
Journal of the American Society of Nephrology : JASN 2019
A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
Y Ouyang, L Zhu, M Shi, S Yu, Y Jin, Z Wang, J Ma, M Yang, X Zhang, X Pan, H Ren, W Wang, H Zhang, J Xie, N Chen
Frontiers in immunology 2019
Association between anti-α-1,4-D-polygalacturonic acid antibodies and Henoch-Schönlein purpura in children
M Miao, X Li, Q Wang, Y Zhu, Y Cui, X Shao
J INT MED RES 2019
The role of complement in IgA nephropathy
A Tortajada, E Gutierrez, MC Pickering, MP Terente, N Medjeral-Thomas
Molecular Immunology 2019
Serum IgA1 shows increased levels of α 2,6-linked sialic acid in breast cancer
HJ Lomax-Browne, C Robertson, A Antonopoulos, AJ Leathem, SM Haslam, A Dell, MV Dwek
Interface Focus 2019
Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study
S Bagchi, R Lingaiah, K Mani, A Barwad, G Singh, V Balooni, D Bhowmik, SK Agarwal, T Shimosawa
PloS one 2019
Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy
D Liu, J You, Y Liu, X Tang, X Tan, M Xia, L Wu, G Chen, L He, X Zhu, H Liu
International Immunopharmacology 2019
Approach to the Child with Hematuria
DD Brown, KJ Reidy
Pediatric Clinics of North America 2019
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
JR Myette, T Kano, H Suzuki, SE Sloan, KJ Szretter, B Ramakrishnan, H Adari, KD Deotale, F Engler, Z Shriver, A Wollacott, Y Suzuki, BJ Pereira
Kidney International 2019
Immunoglobulin A-nephropathy in Russian population: clinical and morphological presentation and long-term prognosis
VA Dobronravov, TO Muzhetskaya, DI Lin, ZS Kochoyan
2019
The Potential Clinical Significance of the Biomarker IgA1
T Robert
Kidney International Reports 2019
Murine Models of Human IgA Nephropathy
H Suzuki, Y Suzuki
Seminars in Nephrology 2018
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
WJ Placzek, H Yanagawa, Y Makita, MB Renfrow, BA Julian, DV Rizk, Y Suzuki, J Novak, H Suzuki, IC Moura
PloS one 2018
The Emerging Role of Pathogenesis of IgA Nephropathy
MY Wu, CS Chen, GT Yiang, PW Cheng, YL Chen, HC Chiu, KH Liu, WC Lee, CJ Li
Journal of Clinical Medicine 2018
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy
J Novak, J Barratt, BA Julian, MB Renfrow
Seminars in Nephrology 2018
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
C Reily, DV Rizk, BA Julian, J Novak
BioTechniques 2018
Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy
C Nguyen, K König, FW Tam, H Hopfer, K Molyneux, FI Binet, MJ Kim
Clinical Kidney Journal 2018
Recent advances in the physiopathology of IgA nephropathy
RC Monteiro
Néphrologie & Thérapeutique 2018
Genetic Determinants of IgA Nephropathy: Western Perspective
YD Neugut, K Kiryluk
Seminars in Nephrology 2018
Effector and regulatory B cells in immune-mediated kidney disease
K Oleinika, C Mauri, A Salama
Nature Reviews Nephrology 2018
15th International Symposium on IgANephropathy - IIgANN 2018, Buenos Aires, September 27-29, 2018: Summaries
Kidney Diseases 2018
Campylobacter rectus in the Oral Cavity Correlates with Proteinuria in Immunoglobulin A Nephropathy Patients
T Misaki, S Naka, K Wato, R Hatakeyama, Y Nagasawa, S Ito, H Inaba, R Nomura, M Matsumoto-Nakano, K Nakano
Nephron. Clinical practice 2018
Biomarkers and Precision Medicine in IgA Nephropathy
FP Schena, SN Cox
Seminars in Nephrology 2018
Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion
H Deng, J Ma, Z Jing, Z Deng, Y Liang, L A, Y Liu, X Qiu, Y Wang
Molecular medicine reports 2018
IgA nephropathy in a patient with IgG Myeloma
BS Lakshmi, SV Devi, NS Sameera, AS Reddy, R Ram, VS Kumar
Indian journal of nephrology 2018
Effector and regulatory B cells in immune-mediated kidney disease
K Oleinika, C Mauri, AD Salama
Nature Reviews Nephrology 2018
Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice
JM Chemouny, PJ Gleeson, L Abbad, G Lauriero, E Boedec, KL Roux, C Monot, M Bredel, J Bex-Coudrat, A Sannier, E Daugas, F Vrtovsnik, L Gesualdo, M Leclerc, L Berthelot, SB Mkaddem, P Lepage, RC Monteiro
Nephrology Dialysis Transplantation 2018
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
K Yamada, ZQ Huang, M Raska, C Reily, JC Anderson, H Suzuki, H Ueda, Z Moldoveanu, K Kiryluk, Y Suzuki, RJ Wyatt, Y Tomino, AG Gharavi, A Weinmann, BA Julian, CD Willey, J Novak
Kidney International Reports 2017
Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome
F Candotti
Journal of Clinical Immunology 2017
What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection
YM Zhang, XJ Zhou, H Zhang
Kidney International Reports 2017
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway
K Kiryluk, Y Li, Z Moldoveanu, H Suzuki, C Reily, P Hou, J Xie, N Mladkova, S Prakash, C Fischman, S Shapiro, RA LeDesma, D Bradbury, I Ionita-Laza, F Eitner, T Rauen, N Maillard, F Berthoux, J Floege, N Chen, H Zhang, F Scolari, RJ Wyatt, BA Julian, AG Gharavi, J Novak, AJ Myers
PLoS genetics 2017
Inflammation in IgA nephropathy
T Rauen, J Floege
Pediatric Nephrology 2017
Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy
AS Alvarado, NK Andeen, S Brodsky, A Hinton, T Nadasdy, CE Alpers, C Blosser, B Najafian, BH Rovin
Nephrology Dialysis Transplantation 2017
Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy: Altered glycosylation of IgG complexes in RA
J Stümer, MH Biermann, J Knopf, I Magorivska, A Kastbom, A Svärd, C Janko, R Bilyy, G Schett, C Sjöwall, M Herrmann, LE Muñoz
Clinical & Experimental Immunology 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
BC Fellström, J Barratt, H Cook, R Coppo, J Feehally, JW de Fijter, J Floege, G Hetzel, AG Jardine, F Locatelli, BD Maes, A Mercer, F Ortiz, M Praga, SS Sørensen, V Tesar, LD Vecchio
The Lancet 2017
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis
M Krochmal, K Cisek, S Filip, K Markoska, C Orange, J Zoidakis, C Gakiopoulou, G Spasovski, H Mischak, C Delles, A Vlahou, J Jankowski
Scientific Reports 2017
Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells
N Persson, N Stuhr-Hansen, C Risinger, S Mereiter, A Polónia, K Polom, A Kovács, F Roviello, CA Reis, C Welinder, L Danielsson, B Jansson, O Blixt
Glycobiology 2017
What insights can proteomics give us into IgA nephropathy (Berger’s disease)?
MB Renfrow, J Novak
Expert Review of Proteomics 2017
Wisteria floribunda agglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases
H Narimatsu, T Sato
Expert Review of Proteomics 2017
Is there a role for immunosuppression in immunoglobulin A nephropathy?
AI Al-Lawati, HN Reich
Nephrology Dialysis Transplantation 2017
Progrès récents dans la maladie de Berger (néphropathie à dépôts d’IgA)
RC Monteiro
Bulletin de l'Académie nationale de médecine 2017
IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition
Z Oruc, C Oblet, A Boumediene, A Druilhe, V Pascal, EL Rumeur, A Cuvillier, CE Hamel, S Lecardeur, T Leanderson, W Morelle, J Demengeot, JC Aldigier, M Cogne
Journal of the American Society of Nephrology : JASN 2016
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
B Knoppova, C Reily, N Maillard, DV Rizk, Z Moldoveanu, J Mestecky, M Raska, MB Renfrow, BA Julian, J Novak
Frontiers in immunology 2016
IgA nephropathy enigma
J Mestecky, J Novak, Z Moldoveanu, M Raska
Clinical Immunology 2016
Immunoglobulin A nephropathy: a pathophysiology view
RC Fabiano, SV Pinheiro, AC Silva
Inflammation Research 2016
Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy
ZQ Huang, M Raska, TJ Stewart, C Reily, RG King, DK Crossman, MR Crowley, A Hargett, Z Zhang, H Suzuki, S Hall, RJ Wyatt, BA Julian, MB Renfrow, AG Gharavi, J Novak
Journal of the American Society of Nephrology : JASN 2016
Markers for the progression of IgA nephropathy
D Maixnerova, C Reily, Q Bian, M Neprasova, J Novak, V Tesar
Journal of Nephrology 2016
Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants
M Dicker, D Maresch, R Strasser
Bioengineered 2016
IgA1 Glycosylation Is Heritable in Healthy Twins
HJ Lomax-Browne, A Visconti, CD Pusey, HT Cook, TD Spector, MC Pickering, M Falchi
Journal of the American Society of Nephrology : JASN 2016
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
MJ Kim, S Schaub, K Molyneux, MT Koller, S Stampf, J Barratt, X Zhou
PloS one 2016
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer
L Cornelissen, SV Vliet
Biomolecules 2016
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins--What Determines the Site of Injury?
M Doshi, A Lahoti, FR Danesh, V Batuman, PW Sanders
Clinical journal of the American Society of Nephrology : CJASN 2016
IgA nephropathy
KN Lai, SC Tang, FP Schena, J Novak, Y Tomino, AB Fogo, RJ Glassock
Nature Reviews Disease Primers 2016
Glycobiology and Human Diseases
YP Lin, M Osburne, M Pereira, J Coburn, J Leong
Glycobiology and Human Diseases 2016
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
K Ebefors, P Liu, E Lassén, J Elvin, E Candemark, K Levan, B Haraldsson, J Nyström
BMC Nephrology 2016
Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro
Q Dai, J Liu, Y Du, X Hao, J Ying, Y Tan, L He, W Wang, N Chen
Acta Pharmacologica Sinica 2016
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft: PGNMID and IgAN in renal allograft
A Sawada, K Kawanishi, S Horita, J Koike, K Honda, A Ochi, M Komoda, Y Tanaka, K Unagami, M Okumi, T Shimizu, H Ishida, K Tanabe, Y Nagashima, K Nitta
Nephrology 2016
Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining: IgAN Oxford Classification validation
G Ştefan, G Ismail, S Stancu, A Zugravu, A Andronesi, E Mandache, G Mircescu
Pathology International 2016
The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease
T Terasaka, HA Uchida, R Umebayashi, K Tsukamoto, K Tanaka, M Kitagawa, H Sugiyama, H Tanioka, J Wada
BMC Nephrology 2016
Advances in Experimental Medicine and Biology
M Mizerska-Wasiak, A Turczyn, A Such, K Cichoń-Kawa, J Małdyk, M Miklaszewska, J Pietrzyk, A Rybi-Szumińska, A Wasilewska, A Firszt-Adamczyk, R Stankiewicz, M Szczepańska, B Bieniaś, M Zajączkowska, A Pukajło-Marczyk, D Zwolińska, K Siniewicz-Luzeńczyk, M Tkaczyk, K Gadomska-Prokop, R Grenda, U Demkow, M Pańczyk-Tomaszewska
Advances in experimental medicine and biology 2016
Systemic Vasculitides: Current Status and Perspectives
E Tombetti, E Baldissera, AA Manfredi, MG Sabbadini
Systemic Vasculitides: Current Status and Perspectives 2016
Presence of Streptococcus mutans strains harbouring the cnm gene correlates with dental caries status and IgA nephropathy conditions
T Misaki, S Naka, R Hatakeyama, A Fukunaga, R Nomura, T Isozaki, K Nakano
Scientific Reports 2016
IgA nephropathy enigma
J Mestecky, J Novak, Z Moldoveanu, M Raska
Clinical Immunology 2016
Pathogenesis and Treatment in IgA Nephropathy
Y Tomino
2016
Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy
F Sallustio, G Serino, SN Cox, AD Gassa, C Curci, GD Palma, B Banelli, G Zaza, M Romani, FP Schena
Clinical Science 2016
Update on immunoglobulin A nephropathy, Part I: Pathophysiology
M Salvadori
World Journal of Nephrology 2015
Molecular Insights into the Pathogenesis of IgA Nephropathy
T Robert, L Berthelot, A Cambier, E Rondeau, RC Monteiro
Trends in Molecular Medicine 2015
Role of IgA receptors in the pathogenesis of IgA nephropathy
SM Lechner, C Papista, JM Chemouny, L Berthelot, RC Monteiro
Journal of Nephrology 2015
New Insights into the Pathogenesis of IgA Nephropathy
J Novak, D Rizk, K Takahashi, XW Zhang, Q Bian, H Ueda, Y Ueda, C Reily, LY Lai, C Hao, L Novak, ZQ Huang, MB Renfrow, H Suzuki, BA Julian
Kidney Diseases 2015
Paradigm shift in activity assessment of IgA nephropathy – optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting
Y Suzuki, H Suzuki, J Yasutake, Y Tomino
Expert Opinion on Biological Therapy 2015
The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up
L Tian, X Shao, Y Xie, L Wang, Q Wang, X Che, Z Ni, S Mou
Expert Opinion on Pharmacotherapy 2015
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
R Plomp, G Dekkers, Y Rombouts, R Visser, CA Koeleman, GS Kammeijer, BC Jansen, T Rispens, PJ Hensbergen, G Vidarsson, M Wuhrer
Molecular & cellular proteomics : MCP 2015
Long-Term Therapeutic Plasma Exchange to Prevent End-Stage Kidney Disease in Adult Severe Resistant Henoch-Schonlein Purpura Nephritis
P Hamilton, O Ogundare, A Raza, A Ponnusamy, J Gorton, H Alachkar, J Choudhury, J Barratt, PA Kalra
Case Reports in Nephrology 2015
Pediatric Nephrology
ED Avner, WE Harmon, P Niaudet, N Yoshikawa, F Emma, S Goldstein
Pediatric Nephrology 2015
SpringerReference Innere Medizin: herausgegeben von Hendrik Lehnert
H Lehnert, SM Schellong, J Mössner, CC Sieber, W Swoboda, A Neubauer, B Kemkes-Matthes, MP Manns, J Rupp, G Hasenfuß, J Floege, M Hallek, T Welte, M Lerch, E Märker-Hermann, LS Weilemann
2015
The genetics and immunobiology of IgA nephropathy
Krzysztof Kiryluk, Jan Novak
Journal of Clinical Investigation 2014
Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*
H Suzuki, M Raska, K Yamada, Z Moldoveanu, BA Julian, RJ Wyatt, Y Tomino, AG Gharavi, J Novak
The Journal of biological chemistry 2014
IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease
Y Narimatsu, A Kuno, H Ito, H Kaji, S Kaneko, J Usui, K Yamagata, H Narimatsu, IC Moura
PloS one 2014
Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
C Reily, H Ueda, ZQ Huang, J Mestecky, BA Julian, CD Willey, J Novak
Journal of Immunology Research 2014
New insights into the pathogenesis of IgA nephropathy
J Floege, IC Moura, MR Daha
Seminars in Immunopathology 2014
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
Y Suzuki, K Matsuzaki, H Suzuki, K Okazaki, H Yanagawa, N Ieiri, M Sato, T Sato, Y Taguma, J Matsuoka, S Horikoshi, J Novak, O Hotta, Y Tomino
Clinical and Experimental Nephrology 2014
Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy
J Nakata, Y Suzuki, H Suzuki, D Sato, T Kano, H Yanagawa, K Matsuzaki, S Horikoshi, J Novak, Y Tomino
PloS one 2014
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases
H Yanagawa, H Suzuki, Y Suzuki, K Kiryluk, AG Gharavi, K Matsuoka, Y Makita, BA Julian, J Novak, Y Tomino
PloS one 2014
Enzymatic sialylation of IgA1 o-glycans: implications for studies of IgA nephropathy
K Takahashi, M Raska, MS Horynova, SD Hall, K Poulsen, M Kilian, Y Hiki, Y Yuzawa, Z Moldoveanu, BA Julian, MB Renfrow, J Novak
PloS one 2014
Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
K Satake, Y Shimizu, Y Sasaki, H Yanagawa, H Suzuki, Y Suzuki, S Horikoshi, S Honda, K Shibuya, A Shibuya, Y Tomino
BMC Nephrology 2014
Development of animal models of human IgA nephropathy
H Suzuki, Y Suzuki, J Novak, Y Tomino
Drug Discovery Today: Disease Models 2014
Immune profile of IgA-dominant diffuse proliferative glomerulonephritis
E Wallace, N Maillard, H Ueda, S Hall, H Fatima, J Novak, BA Julian
Clinical Kidney Journal 2014
Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers
Y Suzuki, H Suzuki, Y Makita, A Takahata, K Takahashi, M Muto, Y Sasaki, A Kelimu, K Matsuzaki, H Yanagawa, K Okazaki, Y Tomino
International journal of nephrology and renovascular disease 2014
N-Acetylgalactosaminide  2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy
MS Horynova, A Vrablikova, TJ Stewart, K Takahashi, L Czernekova, K Yamada, H Suzuki, BA Julian, MB Renfrow, J Novak, M Raska
Nephrology Dialysis Transplantation 2014
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy
R Schmitt, A Stahl, AI Olin, AC Kristoffersson, J Rebetz, J Novak, G Lindahl, D Karpman
Journal of immunology (Baltimore, Md. : 1950) 2014
Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy
M Aizawa, Y Suzuki, H Suzuki, H Pang, M Kihara, J Nakata, K Yamaji, S Horikoshi, Y Tomino
PloS one 2014
O-Linked Glycosylation Determines the Nephritogenic Potential of IgA Rheumatoid Factor
M Kihara, K Ito, J Nakata, M Otani, NL Tran, N Morito, S Takahashi, Y Wada, S Izui
Journal of the American Society of Nephrology : JASN 2014
Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region
Y Hiki, H Hori, K Yamamoto, Y Yamamoto, Y Yuzawa, N Kitaguchi, K Takahashi
Journal of Nephrology 2014
Biomarkers in IgA nephropathy
VJ Hwang, A Ulu, J Hoorebeke, RH Weiss
Biomarkers in Medicine 2014
The etiology of glomerulonephritis: roles of infection and autoimmunity
WG Couser, RJ Johnson
Kidney International 2014
Impact of autoantibody glycosylation in autoimmune diseases
R Goulabchand, T Vincent, F Batteux, J Eliaou, P Guilpain
Autoimmunity Reviews 2014
A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
H Yanagawa, H Suzuki, Y Suzuki, K Kiryluk, AG Gharavi, K Matsuoka, Y Makita, BA Julian, J Novak, Y Tomino, SK Ahuja
PloS one 2014
Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
J Nakata, Y Suzuki, H Suzuki, D Sato, T Kano, H Yanagawa, K Matsuzaki, S Horikoshi, J Novak, Y Tomino, IC Moura
PloS one 2014
Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
K Takahashi, M Raska, MS Horynova, SD Hall, K Poulsen, M Kilian, Y Hiki, Y Yuzawa, Z Moldoveanu, BA Julian, MB Renfrow, J Novak, IC Moura
PloS one 2014
Pathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
K Kiryluk, J Novak, AG Gharavi
Annual Review of Medicine 2013
Biomarkers in IgA nephropathy: relationship to pathogenetic hits
MC Hastings, Z Moldoveanu, H Suzuki, F Berthoux, BA Julian, JT Sanders, MB Renfrow, J Novak, RJ Wyatt
Expert Opinion on Medical Diagnostics 2013
Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: Role of cysteine alkylation during sample processing
V Franc, P Řehulka, M Raus, J Stulík, J Novak, MB Renfrow, M Šebela
Journal of Proteomics 2013
FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy
X Zhou, F Cheng, Y Qi, Y Zhao, P Hou, L Zhu, J Lv, H Zhang
PloS one 2013
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
IgA Nephropathy: Molecular Mechanisms of the Disease
J Mestecky, M Raska, BA Julian, AG Gharavi, MB Renfrow, Z Moldoveanu, L Novak, K Matousovic, J Novak
Annual review of pathology 2013
Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy
R Kolka, H Valdimarsson, M Bodvarsson, S Hardarson, T Jonsson
APMIS 2013
Currently available and potential future treatment options for IgA nephropathy
MJ Kim, FW Tam
Expert Opinion on Orphan Drugs 2013
Pathogenesis of immunoglobulin A nephropathy:
J Novak, MB Renfrow, AG Gharavi, BA Julian
Current Opinion in Nephrology and Hypertension 2013
Antibody Glycosylation and Inflammation
KT Shade, R Anthony
Antibodies 2013
Glomerular Diseases: Emerging Tests and Therapies for IgA Nephropathy
PA Canetta, K Kiryluk, GB Appel
Clinical journal of the American Society of Nephrology : CJASN 2013
Formation des dépôts d’IgA dans la maladie de Berger : ce que révèle le modèle animal
L Berthelot, RC Monteiro
Biologie Aujourd hui 2013
N-acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of IgA nephropathy patients: N-acetylgalactosamine and IgA nephropathy
LX Xu, Z Ye, Z Feng, G Xin, B Zhang, S Liu, R Li, Z Li, X Liang, W Shi
Nephrology 2013
Glycosylation des autoanticorps au cours des maladies auto-immunes
R Goulabchand, F Batteux, P Guilpain
La Revue de Médecine Interne 2013
FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy
X Zhou, F Cheng, Y Qi, Y Zhao, P Hou, L Zhu, J Lv, H Zhang, IC Moura
PloS one 2013
Core Concepts in Parenchymal Kidney Disease
FC Fervenza, J Lin, S Sethi, AK Singh
2013
Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients
MJ Kim, JP McDaid, SP McAdoo, J Barratt, K Molyneux, ES Masuda, CD Pusey, FW Tam
Journal of immunology (Baltimore, Md. : 1950) 2012
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy
G Serino, F Sallustio, SN Cox, F Pesce, FP Schena
Journal of the American Society of Nephrology : JASN 2012
The Glomerular Filtration Barrier: Components and Crosstalk
MC Menon, PY Chuang, CJ He
International Journal of Nephrology 2012
Pathogenesis of IgA nephropathy
KN Lai
Nature Reviews Nephrology 2012
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease
T Inoue, H Iijima, M Tajiri, S Shinzaki, E Shiraishi, S Hiyama, A Mukai, S Nakajima, H Iwatani, T Nishida, T Mizushima, T Yasui, Y Isaka, T Kanto, M Tsujii, E Miyoshi, Y Wada, T Takehara
Inflammatory Bowel Diseases 2012
Suppression of Adiponectin by Aberrantly Glycosylated IgA1 in Glomerular Mesangial Cells In Vitro and In Vivo
T Inoue, H Sugiyama, M Kitagawa, K Takiue, H Morinaga, A Ogawa, Y Kikumoto, S Kitamura, Y Maeshima, H Makino
PloS one 2012
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
J Novak, BA Julian, J Mestecky, MB Renfrow
Seminars in Immunopathology 2012
Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma
MS Horynová, M Raška, H Clausen, J Novak
Cellular and Molecular Life Sciences 2012
In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells
T Yanagihara, R Brown, S Hall, Z Moldoveanu, A Goepfert, M Tomana, BA Julian, J Mestecky, J Novak
Results in Immunology 2012
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy
F Berthoux, H Suzuki, L Thibaudin, H Yanagawa, N Maillard, C Mariat, Y Tomino, BA Julian, J Novak
Journal of the American Society of Nephrology : JASN 2012
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
L Berthelot, C Papista, TT Maciel, M Biarnes-Pelicot, E Tissandie, PH Wang, H Tamouza, A Jamin, J Bex-Coudrat, A Gestin, A Boumediene, M Arcos-Fajardo, P England, E Pillebout, F Walker, E Daugas, F Vrtosvnik, M Flamant, M Benhamou, M Cogne, IC Moura, RC Monteiro
Journal of Experimental Medicine 2012
Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
Y Wada, H Ogata, Y Takeshige, A Takeshima, N Yoshida, M Yamamoto, H Ito, E Kinugasa
Clinical and Experimental Nephrology 2012
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
TM Eison, MC Hastings, Z Moldoveanu, JT Sanders, L Gaber, PD Walker, KK Lau, BA Julian, J Novak, RJ Wyatt
Clinical nephrology 2012
The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
H Tamouza, JM Chemouny, LR Kafkova, L Berthelot, M Flamant, M Demion, L Mesnard, E Paubelle, F Walker, BA Julian, E Tissandié, MK Tiwari, NO Camara, F Vrtovsnik, M Benhamou, J Novak, RC Monteiro, IC Moura
Kidney International 2012
C1GALT1 polymorphisms are associated with Henoch–Schönlein purpura nephritis
X He, P Zhao, S Kang, Y Ding, J Luan, Z Liu, Y Wu, W Yin
Pediatric Nephrology 2012
Immunoglobulin A Nephropathy Associated with Plasmodium falciparum Malaria
DE Yoo, JH Kim, JH Kie, Y Park, TI Chang, HJ Oh, SJ Kim, TH Yoo, KH Choi, SW Kang, SH Han
Journal of Korean Medical Science 2012
IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage
C Zhu, PR Mertens
International Urology and Nephrology 2012
Integrin  1/ 1 and  2/ 1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy
Y Kaneko, T Otsuka, Y Tsuchida, F Gejyo, I Narita
International Immunology 2012
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt
Brenner and Rector's The Kidney 2012
The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
H Tamouza, JM Chemouny, LR Kafkova, L Berthelot, M Flamant, M Demion, L Mesnard, E Paubelle, F Walker, BA Julian, E Tissandié, MK Tiwari, NO Camara, F Vrtovsnik, M Benhamou, J Novak, RC Monteiro, IC Moura
Kidney International 2012
Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
M Shimizu, H Kanegane, T Wada, Y Motoyoshi, T Morio, F Candotti, A Yachie
Journal of Allergy and Clinical Immunology 2012
Jacalin regulates IgA production by peripheral blood mononuclear cells
K Miyamoto, T Chiba, N Shinohara, Y Nagata, N Asakawa, S Kato, N Mizutani, T Murata, S Nomura, T Horiuchi
Immunotherapy 2012
MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders
Y Yuan, S Kasar, C Underbayev, S Prakash, E Raveche
Leukemia Research and Treatment 2012
Suppression of Adiponectin by Aberrantly Glycosylated IgA1 in Glomerular Mesangial Cells In Vitro and In Vivo
T Inoue, H Sugiyama, M Kitagawa, K Takiue, H Morinaga, A Ogawa, Y Kikumoto, S Kitamura, Y Maeshima, H Makino, NO Câmara
PloS one 2012
Mice Over-expressing BAFF Develop a Commensal Flora-Dependent, IgA-Associated Nephropathy
Douglas McCarthy, Julie Kujawa, Cheryl Wilson, Adrian Papandile, Urjana Poreci, Elisa Porfilio, Lesley Ward, Melissa Lawson, Andrew MacPherson, Kathleen McCoy, York Pei, Lea Novak, Jeannette Lee, Bruce Jilian, Jan Novak, Ann Ranger, Jennifer Gommerman, Jeffrey Browning
Journal of Clinical Investigation 2011
Dysfunctions of the Iga system: a common link between intestinal and renal diseases
C Papista, L Berthelot, RC Monteiro
Cellular and Molecular Immunology 2011
Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
M Tanaka, G Seki, T Someya, M Nagata, T Fujita
Clinical and Developmental Immunology 2011
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells
J Novak, LR Kafkova, H Suzuki, M Tomana, K Matousovic, R Brown, S Hall, JT Sanders, TM Eison, Z Moldoveanu, L Novak, Z Novak, R Mayne, BA Julian, J Mestecky, RJ Wyatt
Nephrology Dialysis Transplantation 2011
Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells
M Horynová, K Takahashi, S Hall, MB Renfrow, J Novak, M Raška
Protein Expression and Purification 2011
Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency
M Shimizu, NP Nikolov, K Ueno, K Ohta, RM Siegel, A Yachie, F Candotti
Clinical Immunology 2011
Naturally occurring structural isomers in serum IgA1 o-glycosylation
K Takahashi, AD Smith, K Poulsen, M Kilian, BA Julian, J Mestecky, J Novak, MB Renfrow
Journal of Proteome Research 2011
The pathophysiology of IgA nephropathy
H Suzuki, K Kiryluk, J Novak, Z Moldoveanu, AB Herr, MB Renfrow, RJ Wyatt, F Scolari, J Mestecky, AG Gharavi, BA Julian
Journal of the American Society of Nephrology : JASN 2011
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis
K Kiryluk, Z Moldoveanu, JT Sanders, TM Eison, H Suzuki, BA Julian, J Novak, AG Gharavi, RJ Wyatt
Kidney international. Supplement 2011
O -Glycosylated IgA Rheumatoid Factor Induces IgA Deposits and Glomerulonephritis
M Otani, J Nakata, M Kihara, V Leroy, S Moll, Y Wada, S Izui
Journal of the American Society of Nephrology : JASN 2011
The pathogenesis of IgA nephropathy
RJ Glassock
Current Opinion in Nephrology and Hypertension 2011
Genome-wide association study identifies susceptibility loci for IgA nephropathy
AG Gharavi, K Kiryluk, M Choi, Y Li, P Hou, J Xie, S Sanna-Cherchi, CJ Men, BA Julian, RJ Wyatt, J Novak, JC He, H Wang, J Lv, L Zhu, W Wang, Z Wang, K Yasuno, M Gunel, S Mane, S Umlauf, I Tikhonova, I Beerman, S Savoldi, R Magistroni, GM Ghiggeri, M Bodria, F Lugani, P Ravani, C Ponticelli, L Allegri, G Boscutti, G Frasca, A Amore, L Peruzzi, R Coppo, C Izzi, BF Viola, E Prati, M Salvadori, R Mignani, L Gesualdo, F Bertinetto, P Mesiano, A Amoroso, F Scolari, N Chen, H Zhang, RP Lifton
Nature Genetics 2011
Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and new insights into its molecular mechanisms
A Boumediene, C Oblet, Z Oruc, S Duchez, W Morelle, A Huynh, J Pourrat, JC Aldigier, M Cogne
Nephrology Dialysis Transplantation 2011
Primary IgA Nephropathy: New Insights Into Pathogenesis
J Barratt, J Feehally
Seminars in Nephrology 2011
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89–IgA and IgG–IgA complexes: common mechanisms for distinct diseases
E Tissandié, W Morelle, L Berthelot, F Vrtovsnik, E Daugas, F Walker, D Lebrec, JM Trawalé, C Francoz, F Durand, IC Moura, V Paradis, R Moreau, RC Monteiro
Kidney International 2011
The Pathogenesis of IgA Nephropathy: What is New and How Does it Change Therapeutic Approaches?
J Floege
American Journal of Kidney Diseases 2011
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition
M Raska, K Takahashi, L Czernekova, K Zachova, S Hall, Z Moldoveanu, MC Elliott, L Wilson, R Brown, D Jancova, S Barnes, J Vrbkova, M Tomana, PD Smith, J Mestecky, MB Renfrow, J Novak
The Journal of biological chemistry 2010
Galactosylation of Serum IgA1 O-Glycans in Celiac Disease
K Lindfors, H Suzuki, J Novak, P Collin, P Saavalainen, LL Koskinen, M Mäki, K Kaukinen
Journal of Clinical Immunology 2010
Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1
K Yamada, N Kobayashi, T Ikeda, Y Suzuki, T Tsuge, S Horikoshi, SN Emancipator, Y Tomino
Nephrology Dialysis Transplantation 2010
Genetic studies of IgA nephropathy: past, present, and future
K Kiryluk, BA Julian, RJ Wyatt, F Scolari, H Zhang, J Novak, AG Gharavi
Pediatric nephrology (Berlin, Germany) 2010
Clustered O-Glycans of IgA1
K Takahashi, SB Wall, H Suzuki, AD 4th, S Hall, K Poulsen, M Kilian, JA Mobley, BA Julian, J Mestecky, J Novak, MB Renfrow
Molecular & cellular proteomics : MCP 2010
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study
MM Gomes, H Suzuki, MT Brooks, M Tomana, Z Moldoveanu, J Mestecky, BA Julian, J Novak, AB Herr
Biochemistry 2010
Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
MC Hastings, Z Moldoveanu, BA Julian, J Novak, JT Sanders, KR McGlothan, AG Gharavi, RJ Wyatt
Clinical journal of the American Society of Nephrology : CJASN 2010
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1
SL Hu, GA Colvin, A Rifai, H Suzuki, J Novak, A Esparza, S Farooqi, BA Julian
Nephrology Dialysis Transplantation 2010
Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines
EM Yoo, LJ Yu, LA Wims, D Goldberg, SL Morrison
mAbs 2010
Establishment of a Mouse IgA Nephropathy Model With the MBP-20-Peptide Fusion Protein
L Zhang, F Ye, Y He, D Kong, C Han, Z Zhao, J Zhu, H Meng, X Liu, X Jin
The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2010
Effect of Glycosylation onCis/TransIsomerization of Prolines in IgA1-Hinge Peptide
Y Narimatsu, T Kubota, S Furukawa, H Morii, H Narimatsu, K Yamasaki
Journal of the American Chemical Society 2010
Commentaries on ‘Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura’
M Zaffanello, F Emma, PF Weiss, MC Hastings, TM Eison, RJ Wyatt
Evidence-Based Child Health: A Cochrane Review Journal 2010
Glomérulonéphrite à dépôts mésangiaux d’IgA
É Pillebout, D Nochy
Néphrologie & Thérapeutique 2010
Clustered O -Glycans of IgA1: DEFINING MACRO- AND MICROHETEROGENEITY BY USE OF ELECTRON CAPTURE/TRANSFER DISSOCIATION
K Takahashi, SB Wall, H Suzuki, AD Smith, S Hall, K Poulsen, M Kilian, JA Mobley, BA Julian, J Mestecky, J Novak, MB Renfrow
Molecular & cellular proteomics : MCP 2010
Recognition of Galactose-Deficient O -Glycans in the Hinge Region of IgA1 by N -Acetylgalactosamine-Specific Snail Lectins: A Comparative Binding Study
MM Gomes, H Suzuki, MT Brooks, M Tomana, Z Moldoveanu, J Mestecky, BA Julian, J Novak, AB Herr
Biochemistry 2010
Aberrantly Glycosylated IgA1 in IgA Nephropathy Patients is Recognized by IgG Antibodies with Restricted Heterogeneity
Hitoshi Suzuki, Run Fan, Zhixin Zhang, Rhubell Brown, Stacy Hall, Bruce A. Julian, W. Winn Chatham, Yusuke Suzuki, Robert J. Wyatt, Zina Moldoveanu, Jeannette Y. Lee, James Robinson, Milan Tomana, Yasuhiko Tomino, Jiri Mestecky, Jan Novak
Journal of Clinical Investigation 2009
Role of IgA and IgA Fc Receptors in Inflammation
RC Monteiro
Journal of Clinical Immunology 2009
Pathogenesis of Henoch-Schönlein purpura nephritis
KK Lau, H Suzuki, J Novak, RJ Wyatt
Pediatric Nephrology 2009
Vasculitis of small blood vessels - some riddles about IgA and about the complexity of transmigration
C Sunderkötter
Experimental Dermatology 2009
Pathogenetic Analyses of IgA nephropathy from the aspect of O-glycans in IgA1 hinge region
Y Hiki
Nihon Shoni Jinzobyo Gakkai Zasshi 2009
IgA nephropathy--the case for a genetic basis becomes stronger
K Kiryluk, AG Gharavi, C Izzi, F Scolari
Nephrology Dialysis Transplantation 2009
Tissue distribution and biological activities of immune complexes are determined by their size and composition
K Matousovic, J Novak, BA Julian, J Mestecky
Nephrology Dialysis Transplantation 2009
IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy
A Jacquet, H Francois, C Frangie, Y Yahiaoui, S Ferlicot, C Micelli, X Mariette, A Durrbach
Nephrology Dialysis Transplantation 2009
Genetic Diseases of the Kidney
K Ichida, M Hosoyamada, T Hosoya, H Endou
Genetic Diseases of the Kidney 2009
Challenges to enigmas in the pathogenesis of IgA nephropathy
Y Suzuki
Juntendo Medical Journal 2009
O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy
Y Hiki
Clinical and Experimental Nephrology 2009
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly-glycosylated IgA1
Hitoshi Suzuki, Zina Moldoveanu, Stacy Hall, Rhubell Brown, Huong L. Vu, Lea Novak, Bruce A. Julian, Milan Tomana, Robert J. Wyatt, Jeffrey C. Edberg, Graciella S. Alarcón, Robert P. Kimberly, Yasuhiko Tomino, Jiri Mestecky, Jan Novak
Journal of Clinical Investigation 2008
Potential Immunopathogenic Role of the Mucosa–Bone Marrow Axis in IgA Nephropathy: Insights From Animal Models
Y Suzuki, Y Tomino
Seminars in Nephrology 2008
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy
I Narita, F Gejyo
Clinical and Experimental Nephrology 2008
Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding
MM Gomes, SB Wall, K Takahashi, J Novak, MB Renfrow, AB Herr
Biochemistry 2008
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy
J Novak, BA Julian, M Tomana, J Mestecky
Seminars in Nephrology 2008
Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy
J Mestecky, M Tomana, Z Moldoveanu, BA Julian, H Suzuki, K Matousovic, MB Renfrow, L Novak, RJ Wyatt, J Novak
Kidney and Blood Pressure Research 2008
Recent insights into the biological roles of mucin-type O-glycosylation
E Tian, KG Hagen
Glycoconjugate Journal 2008
T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy
SR Chintalacharuvu, M Yamashita, N Bagheri, TG Blanchard, JG Nedrud, ME Lamm, Y Tomino, SN Emancipator
Clinical & Experimental Immunology 2008
Sweet preferences of MGL: carbohydrate specificity and function
SJ van Vliet, E Saeland, Y Kooyk
Trends in Immunology 2008
Gastrointestinal Manifestations of Henoch-Schonlein Purpura
EC Ebert
Digestive Diseases and Sciences 2008
Capillary electrophoresis–mass spectrometry in urinary proteome analysis: current applications and future developments
J Metzger, JP Schanstra, H Mischak
Analytical and Bioanalytical Chemistry 2008
The Glomerular Response to IgA Deposition in IgA Nephropathy
IC Moura, M Benhamou, P Launay, F Vrtovsnik, U Blank, RC Monteiro
Seminars in Nephrology 2008
Secondary IgA Nephropathy
S Pouria, J Barratt
Seminars in Nephrology 2008
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
AG Gharavi, Z Moldoveanu, RJ Wyatt, CV Barker, SY Woodford, RP Lifton, J Mestecky, J Novak, BA Julian
Journal of the American Society of Nephrology : JASN 2008
Analysis of IgA1 N -Glycosylation and Its Contribution to FcαRI Binding
MM Gomes, SB Wall, K Takahashi, J Novak, MB Renfrow, AB Herr
Biochemistry 2008
Protective role of anti-synthetic hinge peptide antibody for glomerular deposition of hypoglycosylated IgA1
Y Hiki, K Takahashi, S Shimozato, H Odani, K Yamamoto, M Tomita, M Hasegawa, K Murakami, K Nabeshima, S Nakai, Y Fujita, I Ishida, H Iwase, S Sugiyama
Clinical and Experimental Nephrology 2008
Development of Immunoglobulin A Nephropathy- Like Disease in β-1,4-Galactosyltransferase-I-Deficient Mice
T Nishie, O Miyaishi, H Azuma, A Kameyama, C Naruse, N Hashimoto, H Yokoyama, H Narimatsu, T Wada, M Asano
The American Journal of Pathology 2007
Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the Future
DM Good, V Thongboonkerd, J Novak, JL Bascands, JP Schanstra, JJ Coon, A Dominiczak, H Mischak
Journal of Proteome Research 2007
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z Moldoveanu, RJ Wyatt, JY Lee, M Tomana, BA Julian, J Mestecky, WQ Huang, SR Anreddy, S Hall, MC Hastings, KK Lau, WJ Cook, J Novak
Kidney International 2007
Hypercomplementemia in adult patients with IgA nephropathy
K Onda, H Ohi, M Tamano, I Ohsawa, M Wakabayashi, S Horikoshi, T Fujita, Y Tomino
Journal of Clinical Laboratory Analysis 2007
Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells
H Suzuki, Y Suzuki, M Aizawa, T Yamanaka, M Kihara, H Pang, S Horikoshi, Y Tomino
Kidney International 2007
The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy (Review Article)
J Barratt, AC Smith, J Feehally
Nephrology 2007
The genetics of IgA nephropathy
I Beerman, J Novak, RJ Wyatt, BA Julian, AG Gharavi
Nature Clinical Practice Nephrology 2007
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells
M Raska, Z Moldoveanu, H Suzuki, R Brown, R Kulhavy, J Andrasi, S Hall, HL Vu, F Carlsson, G Lindahl, M Tomana, BA Julian, RJ Wyatt, J Mestecky, J Novak
Journal of Molecular Biology 2007
Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules
YH Gao, LX Xu, JJ Zhang, Y Zhang, MH Zhao, HY Wang
Clinical & Experimental Immunology 2007
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins
JS Moore, R Kulhavy, M Tomana, Z Moldoveanu, H Suzuki, R Brown, S Hall, M Kilian, K Poulsen, J Mestecky, BA Julian, J Novak
Molecular Immunology 2007
Immunopathogenesis of IgAN
J Barratt, AC Smith, K Molyneux, J Feehally
Seminars in Immunopathology 2007
The genetic susceptibility to IgA nephropathy: A novel functional candidate gene for incomplete O-glycosylation of IgA1
I Narita, Y Kaneko, D Kondo, S Goto, M Sakatsume, F Gejyo
Kidney International 2007
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases
BA Julian, S Wittke, M Haubitz, P Zürbig, E Schiffer, BM McGuire, RJ Wyatt, J Novak
World Journal of Urology 2007
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura
KK Lau, RJ Wyatt, Z Moldoveanu, M Tomana, BA Julian, RJ Hogg, JY Lee, WQ Huang, J Mestecky, J Novak
Pediatric Nephrology 2007
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy
MB Renfrow, CL Mackay, MJ Chalmers, BA Julian, J Mestecky, M Kilian, K Poulsen, MR Emmett, AG Marshall, J Novak
Analytical and Bioanalytical Chemistry 2007
Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy
JX Ding, LX Xu, JC Lv, MH Zhao, H Zhang, HY Wang
Clinical Immunology 2007
Glycosylation Profile of Differently Charged IgA1 and Their Binding Characteristics to Cultured Mesangial Cells in IgA Nephropathy
JC Leung, LY Chan, SC Tang, PC Tam, J Fenn, KN Lai
Nephron Experimental Nephrology 2007
Mucosal Immune Defense: Immunoglobulin A
CS Kaetzel
2007
Th2 cytokine induces aberrant O-glycosylation in the hinge region of IgA1 via downregulation of core1β1, 3-galactosyltransferase and its molecular chaperone Cosmc
K Yamada, N Kobayashi, T Ikeda, Y Suzuki, T Tsuge, S Horikoshi, Y Tomino
Juntendo Medical Journal 2007
Concurrent Antiglomerular Basement Membrane Disease and Immune Complex Glomerulonephritis
Z Cui, MH Zhao, SX Wang, G Liu, WZ Zou, HY Wang
Renal Failure 2006
Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy
Y Yan, LX Xu, JJ Zhang, Y Zhang, MH Zhao
Clinical & Experimental Immunology 2006
A destructive nasal lesion and glomerulonephritis
FP Wilson, SH Nasr, GS Markowitz, EC Naylor, PL Sterman, VD D'Agati
Kidney International 2006
IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential
MM Gomes, AB Herr
Springer Seminars in Immunopathology 2006
Reconciling solvent effects on rotamer populations in carbohydrates — A joint MD and NMR analysis
J Gonzalez-Outeiriño, KN Kirschner, S Thobhani, RJ Woods
Canadian Journal of Chemistry 2006
IgA nephropathy in two adolescent sisters heterozygous for Fabry disease
C Whybra, A Schwarting, J Kriegsmann, A Gal, E Mengel, C Kampmann, F Baehner, E Schaefer, M Beck
Pediatric Nephrology 2006
Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells
J Zhang, L Xu, Y Zhang, M Zhao
Clinical Immunology 2006
Experimental model of IgA nephropathy using KM mouse (second report): Possible protective effect of anti-IgA1 synthetic hinge peptide antibody on glomerular deposition of underglycosylated IgA1
Y Hiki, K Takahashi, M Itoh, K Inoue, M Tomita, M Hasegawa, K Murakami, K Nabeshima, I Ishida, H Iwase, S Sugiyama
Nephrology 2006
Increased Prevalence of Anti-Gliadin IgA-Antibodies with Aberrant Duodenal Histopathological Findings in Patients with IgA-Nephropathy and Related Disorders
G Almroth, T Axelsson, E Müssener, E Grodzinsky, G Midhagen, P Olcén
Upsala Journal of Medical Sciences 2006
Glomérulonéphrite à dépôts mésangiaux d'IgA
E Pillebout, D Nochy
EMC - Néphrologie 2006
IgA-containing immune complexes in the urine of IgA nephropathy patients
K Matousovic, J Novak, T Yanagihara, M Tomana, Z Moldoveanu, R Kulhavy, BA Julian, K Konecny, J Mestecky
Nephrology Dialysis Transplantation 2006
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells
J Novak, M Tomana, K Matousovic, R Brown, S Hall, L Novak, BA Julian, RJ Wyatt, J Mestecky
Kidney International 2005
Role of macromolecular IgA in IgA nephropathy
PJ van der Boog, C Kooten, JW de Fijter, MR Daha
Kidney International 2005
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy
LX Xu, Y Yan, JJ Zhang, Y Zhang, MH Zhao
Clinical & Experimental Immunology 2005
The function of immunoglobulin A in immunity
JM Woof, MA Kerr
The Journal of Pathology 2005
IgA: An immune glycoprotein
EM Yoo, SL Morrison
Clinical Immunology 2005
Small bowel cyclooxygenase 2 (COX-2) expression in patients with IgA nephropathy
T Honkanen, J Mustonen, H Kainulainen, J Myllymaki, P Collin, M Hurme, I Rantala
Kidney International 2005
Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy
LX Xu, MH Zhao
Kidney International 2005
Mucosal Immunology
WR Brown
Mucosal Immunology 2005
Determination of Aberrant O- Glycosylation in the IgA1 Hinge Region by Electron Capture Dissociation Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry
MB Renfrow, HJ Cooper, M Tomana, R Kulhavy, Y Hiki, K Toma, MR Emmett, J Mestecky, AG Marshall, J Novak
The Journal of biological chemistry 2005
FcγRIIa-131R allele and FcγRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy
Y Tanaka, Y Suzuki, T Tsuge, Y Kanamaru, S Horikoshi, RC Monteiro, Y Tomino
Nephrology Dialysis Transplantation 2005
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice
R Marquina, MA Díez, M López-Hoyos, L Buelta, A Kuroki, S Kikuchi, J Villegas, M Pihlgren, CA Siegrist, M Arias, S Izui, J Merino, R Merino
Journal of immunology (Baltimore, Md. : 1950) 2004
Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes*
I Nakamura, H Iwase, K Arai, Y Nagai, K Toma, T Katsumata, Y Hiki, T Kokubo, T Sano, Y Kobayashi
Nephrology 2004
Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy
O Hotta
Seminars in Nephrology 2004
Aberrant glycosylation in IgA nephropathy (IgAN)
R Coppo, A Amore
Kidney International 2004
Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy
A Koyama, S Sharmin, H Sakurai, Y Shimizu, K Hirayama, J Usui, M Nagata, K Yoh, K Yamagata, K Muro, M Kobayashi, K Ohtani, T Shimizu, T Shimizu
Kidney International 2004
An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy
PJ van der Boog, C Kooten, A Seggelen, M Mallat, N Klar-Mohamad, JW de Fijter, MR Daha
Nephrology Dialysis Transplantation 2004
Is IgA nephropathy induced by hyperproduction of interferon-α?
EN Wardle
Medical Hypotheses 2004
IgA nephropathy: an update:
BA Julian, J Novak
Current Opinion in Nephrology and Hypertension 2004
Development of IgA nephritis following cat scratch disease in a 13-year-old boy
L Hopp, SC Eppes
Pediatric Nephrology 2004
IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy
A Horie, Y Hiki, H Odani, Y Yasuda, M Takahashi, M Kato, H Iwase, Y Kobayashi, I Nakashima, K Maeda
American Journal of Kidney Diseases 2003
Complexes of IgA with FcαRI/CD89 are not specific for primary IgA nephropathy
PJ van der Boog, JW de Fijter, C Kooten, R der Holst, A Seggelen, LA van Es, MR Daha
Kidney International 2003
Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits
E Haddad, IC Moura, M Arcos-Fajardo, MA Macher, V Baudouin, C Alberti, C Loirat, RC Monteiro, M Peuchmaur
Journal of the American Society of Nephrology : JASN 2003
Henoch-Schonlein purpura nephritis
FC Fervenza
International Journal of Dermatology 2003
Pathogénie de la maladie de Berger : implication des immunoglobulines A et de leurs récepteurs
RC Monteiro, V Leroy, P Launay, IC Moura, M Arcos-Fajardo, M Benhamou, É Haddad
médecine/sciences 2003
Interactions of human mesangial cells with IgA and IgA-containing immune complexes1
J Novak, HL Vu, L Novak, BA Julian, J Mestecky, M Tomana
Kidney International 2002
Pathogenic significance of IgA receptor interactions in IgA nephropathy
RC Monteiro, IC Moura, P Launay, T Tsuge, E Haddad, M Benhamou, MD Cooper, M Arcos-Fajardo
Trends in Molecular Medicine 2002
Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy
J MESTECKY, J NOVAK, BA JULIAN, M TOMANA
Nephrology 2002
IgA-Nephropathie
J Floege, HJ Grne
Der Internist 2002
Identification of the Transferrin Receptor as a Novel Immunoglobulin (Ig)a1 Receptor and Its Enhanced Expression on Mesangial Cells in Iga Nephropathy
IC Moura, MN Centelles, M Arcos-Fajardo, DM Malheiros, JF Collawn, MD Cooper, RC Monteiro
Journal of Experimental Medicine 2001
Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy
Y Hiki, H Odani, M Takahashi, Y Yasuda, A Nishimoto, H Iwase, T Shinzato, Y Kobayashi, K Maeda
Kidney International 2001
T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation
SR Chintalacharuvu, NU Nagy, N Sigmund, JG Nedrud, ME Amm, SN Emancipator
Clinical & Experimental Immunology 2001
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy
IC Moura, MN Centelles, M Arcos-Fajardo, DM Malheiros, JF Collawn, MD Cooper, RC Monteiro
Journal of Experimental Medicine 2001
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients
AC Allen, EM Bailey, PE Brenchley, KS Buck, J Barratt, J Feehally
Kidney International 2001
Chemoenzymatic Synthesis of Biotinylated Nucleotide Sugars as Substrates for Glycosyltransferases
T Bülter, T Schumacher, DJ Namdjou, RG Gallego, H Clausen, L Elling
ChemBioChem 2001
Henoch-Sch??nlein purpura
FT Saulsbury
Current Opinion in Rheumatology 2001
Hypersialylated macromolecular serum immunoglobulin A1 in type 2 diabetes mellitus
L Vázquez–Moreno, MC Candia–Plata, MR Robles–Burgueño
Clinical Biochemistry 2001
Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells
A Amore, P Cirina, G Conti, P Brusa, L Peruzzi, R Coppo
Journal of the American Society of Nephrology : JASN 2001
Severe non‐proliferative lupus nephritis with predominant sub‐endothelial IgA deposits
S Florquin, A Roos, JW Groothoff, N Claessen, DJ van GijlswijkJanssen, J Aten, JC Davin, JJ Weening
Nephrology Dialysis Transplantation 2001
Progress in molecular and genetic studies of IgA nephropathy
J Novak, B A Julian, M Tomana, J Mesteck
Journal of Clinical Immunology 2001
Evidence for genetic factors in the development and progression of IgA nephropathy
SI Hsu, SB Ramirez, MP Winn, JV Bonventre, WF Owen
Kidney International 2000
Heterogeneity of O-glycosylation in the hinge region of human IgA1
J Novak, M Tomana, M Kilian, L Coward, R Kulhavy, S Barnes, J Mestecky
Molecular Immunology 2000
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes
A Rifai, K Fadden, SL Morrison, KR Chintalacharuvu
Journal of Experimental Medicine 2000
Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice
P Launay, B Grossetête, M Arcos-Fajardo, E Gaudin, SP Torres, L Beaudoin, NP de Serre, A Lehuen, RC Monteiro
Journal of Experimental Medicine 2000
Authors' reply:
Y Hisada, T Sugaya
American Journal of Kidney Diseases 2000
Fc  Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease): Evidence for Pathogenic Soluble Receptor-Iga Complexes in Patients and Cd89 Transgenic Mice
P Launay, B Grossetete, M Arcos-Fajardo, E Gaudin, SP Torres, L Beaudoin, NP de Serre, A Lehuen, RC Monteiro
Journal of Experimental Medicine 2000
The N-Glycans Determine the Differential Blood Clearance and Hepatic Uptake of Human Immunoglobulin (Ig)a1 and Iga2 Isotypes
A Rifai, K Fadden, SL Morrison, KR Chintalacharuvu
Journal of Experimental Medicine 2000
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis
AM Zickerman, AC Allen, V Talwar, SA Olczak, A Brownlee, M Holland, PN Furness, NJ Brunskill, J Feehally
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000
IgA1 glycosylation and the pathogenesis of IgA nephropathy
AC Allen, J Feehally
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000
IgA Nephropathy: Recent Developments
J Floege, J Feehally
Journal of the American Society of Nephrology : JASN 2000
IgA nephropathy
TE Hunley, V Kon
Current Opinion in Pediatrics 1999
Pathogenesis of IgA nephropathy
LA ES, JW FIJTER, M Daha
Nephrology 1997
Rheumatology
RA Asherson, R Cervera, DP D'Cruz, GR Hughes
Postgraduate medical journal 1991
Autoantibodies
MH Lessof, SP Asper
American Heart Journal 1960

← Previous 1 2 3 … 15 16 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
108 readers on Mendeley
See more details